Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results

Go back to Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results
(NASDAQ: EPRX) Delayed: 6.37 -0.09 (1.39%)
Previous Close $6.46    52 Week High
Open $6.46    52 Week Low
Day High $6.53    P/E N/A 
Day Low $6.34    EPS
Volume 23,791       

(NASDAQ: EPRX) Delayed: 6.37 -0.09 (1.39%)
Previous Close $6.46    52 Week High
Open $6.46    52 Week Low
Day High $6.53    P/E N/A 
Day Low $6.34    EPS
Volume 23,791